The EFPIA disclosure code was transposed in to “The Ethical rules of the pharmaceutical Industry in Sweden” from 1 January 2014.
Parallel to this actual code transposition, LIF also informed important stakeholders about the initiative trough meetings and personal communication. All major stakeholders was positive to the transparency initiative, with the result that LIF signed letters of intent with “The Swedish Medical Association” and “The Swedish Association of Health Professionals”, where they voice their support for the initiative.Sweden-map-colour
LIF has also produced materials and guidance, aimed at pharmaceutical companies as well as HCPs and HCOs. We have produced an informative brochure about the initiative that can be ordered from LIFs website at no cost, with the intent to be used by the member companies when informing HCPs about this important initiative.
In September 2014, LIF sent a personal letter to every doctor in Sweden about the initiative. We wanted to make sure that all doctors were informed about the initiative in ample time before 2015, i.e. when the actual collection of data would take place by the pharmaceutical companies.
The feedback we get from our member companies is that this transparency initiative is being received quite well from the HCPs and HCOs in Sweden, thus we expect a high consent level from the HCPs.
[Read more…]